© 2015

Holographic Sensors


Part of the Springer Theses book series (Springer Theses)

Table of contents

  1. Front Matter
    Pages i-xviii
  2. Ali Kemal Yetisen
    Pages 1-25
  3. Ali Kemal Yetisen
    Pages 27-51
  4. Ali Kemal Yetisen
    Pages 53-83
  5. Ali Kemal Yetisen
    Pages 85-99
  6. Ali Kemal Yetisen
    Pages 101-134
  7. Ali Kemal Yetisen
    Pages 135-148
  8. Ali Kemal Yetisen
    Pages 149-162

About this book


This thesis presents a theoretical and experimental approach for the rapid fabrication, optimization and testing of holographic sensors for the quantification of pH, organic solvents, metal cations, and glucose in solutions.
Developing non-invasive and reusable diagnostics sensors that can be easily manufactured will support the monitoring of high-risk individuals in any clinical or point-of-care setting. Sensor fabrication approaches outlined include silver-halide chemistry, laser ablation and photopolymerization. The sensors employ off-axis Bragg diffraction gratings of ordered silver nanoparticles and localized refractive index changes in poly (2-hydroxyethyl methacrylate) and polyacrylamide films. The sensors exhibited reversible Bragg peak shifts, and diffracted the spectrum of narrow-band light over the wavelength range λpeak ≈ 495-1100 nm. Clinical trials of glucose sensors in the urine samples of diabetic patients demonstrated that they offer superior performance compared to commercial high-throughput urinalysis devices. Lastly, a generic smartphone application to quantify colorimetric tests was developed and tested for both Android and iOS operating systems. The sensing platform and smartphone application may have implications for the development of low-cost, reusable and equipment-free point-of-care diagnostic devices.


Bragg Gratings Diagnostics Holography Mobile Medical Applications Nanoparticles Paper-based Diagnostics Point-of-Care Sensors Smartphone Applications Telemedicine

Authors and affiliations

  1. 1.Department of Chemical Engineering and BiotechnologyUniversity of CambridgeCambridgeUnited Kingdom

About the authors

Ali Yetisen received his B.Sc. degree in Mechanical Engineering from the University of Arizona in 2010, and his Ph.D. in Biotechnology from the University of Cambridge in 2014. His research interests are nanotechnology, nanoparticles, diagnostics, biomaterials and drug delivery. He has taught entrepreneurship and commercialization courses at the Judge Business School in Cambridge. Ali has published 25 journal articles and has a patent licenced to Hoffmann-La Roche. He has been the recipient of The Ann & Norman Hilberry Scholarship, Roche Continents Award, and Cambridge Infectious Diseases Fellowship. Currently, Ali serves as a reviewer for 20 journals in nanotechnology.

Bibliographic information